Hashtag HPV: HPV Vaccine Twitter Education Program
Human Papilloma Virus, Vaccine-Preventable Diseases
About this trial
This is an interventional prevention trial for Human Papilloma Virus focused on measuring Human Papilloma Virus, Human Papilloma Virus Vaccine, Human Papilloma Virus Vaccination, Intervention, Social media, Twitter, Parents, Child health, Cancer prevention, Vaccine acceptance, Narrative engagement, Patient self-report, Intention to vaccinate, community engagement, Public Health, Vaccination
Eligibility Criteria
Inclusion Criteria: The study population includes parents who have children ages 9-14. All participants will be 18 years of age or older, and we will specifically target parents ages 25 and older. Eligibility for enrollment in the study will be limited to the following criteria:
- Adults 18 years of age and older;
- Utilizes Twitter, a social media platform;
- Has a child aged 9-14;
- Child has not started the 2-dose HPV vaccination series;
- Has no child who has completed any dose HPV vaccination series;
- Has a well-care visit scheduled for their child before December, 2022.
Exclusion Criteria:
- Any adult who does not have a child 9-14 years of age;
- Any adult who does not indicate some level of participation in Twitter;
- Any adults who indicates a high level of anti-vaccine sentiment (assessed by vaccine hesitancy questions asked in the screener).
Sites / Locations
- University of Arkansas
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Narrative
Non-Narrative
The intervention condition will present narrative-focused messages about HPV and the HPV vaccine that includes important parent focused exemplar language and cultural norms on Twitter told through stories and characters (i.e., pseudo-parents).
The non-narrative condition will present scientific-focused messages about HPV and the HPV vaccine that includes important information relayed with numbers and facts.